Singapore SUMMARY A total of 136 patients with uncomplicated gonorrhoea were treated with intramuscular cefoxitin 2 g (25 patients) or 1 g ( 11 patients) and oral probenecid 1 g. Cefoxitin 1 g cured 95% (42 out of 45 men and all of 14 women) with infections caused by penicillinase producing Neissera gonorrhoeae (PPNG) strains and 98% (all of 38 men and 13 out of 14 women) with non-PPNG infections, giving an overall cure rate of 96%. The rate ofpostgonococcal urethritis (PGU) in men treated with 1 g cefoxitin was 28%. No serious side effects oftreatment were observed in patients treated with either dose. The failure rate of 7% in men infected with PPNG strains who were treated with the 1 g dose is, however,disturbing. We therefore recommend that intramuscular cefoxitin 2 g and oral probenecid 1 g may be used to treat uncomplicated gonorrhoea, especially in areas where PPNG strains are common.
Introduction
For several years the gonococcus has shown itselfto be a highly adaptable organism that resisted the onslaught of antibiotics. Relative resistance to penicillins emerged in the 1950s, when strains with minimum inhibitory concentrations (MICs) of more than 0-018 mg/l penicillin appeared. By the early 1970s, MICs of penicillin were 05 mg/l or more for 45% or more of gonococcal strains isolated in South East Asia and the Philippines.' To overcome the problem of increasing resistance, the dose ofprocaine penicillin G increased from 1 2 MIU to 4 8 MIU combined with probenecid.
Even such high dose penicillin treatment, however, K B Lim, T Thirumoorthy, C T Lee, S N Tham, E H Sng, and T Tan due to PPNG strains and 13 (93%) of 14 cases due to non-PPNG strains were cured, giving an overall cure rate of (96%) (27/28).
SENSITIVITY TO ANTIBIOTIC Table II shows the results of antibiotic susceptibility tests. The geometric mean MICs were 1'31 mg/l for PPNG strains and 1'21 mg/l for non-PPNG strains. MICs of 2 mg/l or more were found in 55% of the PPNG isolates and 51% of the non-PPNG isolates. The difference in the distribution of the MICs of PPNG and non-PPNG strains using the Wilcoxon rank sum test was not significant (p > 0-05). 
Discussion
Cefoxitin is a cephamycin derivative with good in vitro activity against Ngonorrhoeae. Its stability to penicillinase and its pharmacokinetic characteristics showed that it had potential for treating gonorrhoea caused by PPNG and non-PPNG strains ? 10 Initial studies by Berg etal in 1979 showed cefoxitin 2 g and probenecid 1 g to be effective,6 and a 1 g dose of cefoxitin has been shown to be equally effective in a small number of patients (Sanchez PL, et al, unpublished observation). Because of the ability of the gonococcus to develop resistance, we ran a pilot study to assess whether cefoxitin 2 g with probenecid was still effective in the Cefoxitin 1 or 2 g with probenecid is a safe regimen, which has no major side effects. Pain from intramuscular cefoxitin of variable severity was experienced by all patients when they were asked specifically. The severity of pain may be reduced by incorporating lignocaine in the injection, as is recommended by the manufacturers. Cefoxitin Ig is ineffective in treating PGU and additional treatment is required for this. Cefoxitin 2 g, rather than 1 g, should be used with probenecid in areas where PPNG strains are prevalent, as the 1 g dose may be associated with a 7% failure rate in men infected with PPNG strains.
